Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran vs Apixaban in Cerebral Venous Thrombosis
NCT06551415Phase 3Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Aug 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dabigatran in Cerebral venous thrombosis (CVT), sponsored by Kafrelsheikh University. Started Aug 2021; status: recruiting.
02
Drugs
dabigatran
03
Conditions
Cerebral venous thrombosis (CVT)
Beyond the preview
Go deeper on NCT06551415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06551415.